Induction of apoptosis in T98G glioblastoma cells by transfection of GML, a p53 target gene

Oncology Research

Volumn 11, Issue 3, 1999, Pages 125-132

  Ueda, Kazuki ^a   Miyoshi, Yasuo ^a   Tokino, Takashi ^a   Watatani, Masahiro ^a   Nakamura, Yusuke ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; GML: P53 target; T98G

Indexed keywords

CELL CYCLE PROTEIN; GML PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN P53; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; COLORECTAL TUMOR; DRUG SCREENING; GENETICS; GLIOBLASTOMA; HUMAN; PATHOLOGY;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL DIVISION; COLORECTAL NEOPLASMS; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032620563     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88:323-331; 1997.
2. Kastan, M. B.; Zhan, Q.; El-Diery, W. S.; Carrier, R; Jacks, T.; Walsh, W. V.; Plunkett, B. S.; Vogelstein, B.; Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71:587-597; 1992.
3. Canman, C. E.; Kastan, M. B. Small contribution of Gl checkpoint control manipulation to modulation of p53-mediated apoptosis. Oncogene 16:957-966; 1998.
4. Cayrol, C.; Knibiehler, M.; Ducommun, B. p21 binding to PCNA causes Gl and G2 cell cycle arrest in p53-deficient cells. Oncogene 16:311-320; 1998.
5. Naumovski, L.; Cleary, M. L. The p53-binding protein 53BP2 also interacts with BcI2 and impedes cell cycle progression at G2/M. Mol. Cell. Biol. 16:3884-3892; 1996.
6. Shiratsuchi, T.; Futamura, M.; Oda, K.; Nishimori, H.; Nakamura, Y.; Tokino, T. Cloning and characterization of BAI-associated protein 1: A PDZ domain-containing protein that interacts with BAIL Biochem. Biophys. Res. Commun. 247:597-6CM; 1998.
7. Bouvet, M.; Ellis, L. M.; Nishizaki, M.; Fujiwara, T.; Liu, W.; Bucana, C. D.; Fang, B.; Lee, J. J.; Roth, J. A. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58:2288-2292; 1998.
8. Weller, M. Predicting response to cancer chemotherapy: The role of p53. Cell Tissue Res. 292:435-445; 1998.
9. Lutzker, S.; Levine, A. J. A functionally inactive p53 protein in embryonal carcinoma cells is activated by DNA damage or cellular différenciation. Nat. Med. 2:804-810; 1996.
10. Aas, T.; Borresen, A.-L.; Geisler, S.; Smith-Sorensen, B.; Johnsen, H.; Vargaug, J. E.; Akslen, L. A.; Lonning, P. E. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med. 2:811-814; 1996.
11. Ceraline, J.; Deplanque, G.; Duclos, B.; Limacher, J.-M.; Hajri, A.; Noel, F.; Orvain, C.; Frebourg, T.; Klein-Soyer, C.; Bergerat, J.-P. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. Int. J. Cancer 75: 432-438; 1998.
12. Bragosklonny, M. V.; El-Diery, W. S. Acute overexpression of WT p53 facilitates anticancer drug-induced death of cancer and normal cells. Int. J. Cancer 75:933-940; 1998.
13. Casey, G.; Lo-Hsueh, M.; Lopez, M. E.; Vogelstein, B.; Stanbridge, E. J. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 6:1791-1797; 1991.
14. Furuhata, T.; Tokino, T.; Urano, T.; Nakamura, Y. Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity. Oncogene 13:1965-1970; 1996.
15. Kimura, Y.; Furuhata, T.; Shiratsuchi, T.; Nishimori, H.; Hirata, K.; Nakamura, Y.; Tokino, T. GML sensitizes cancer cells to taxol by induction of apoptosis. Oncogene 15:1369-1374; 1997.
16. Kagawa, K.; Inoue, T.; Tokino, T.; Nakamura, Y.; Akiyama, T. Overexpressîon of GML promotes radiation-induced cell cycle arrest and apoptosis. Biochem. Biophys. Res. Commun. 241:481-485; 1997.
17. Gossen, M.; Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promotors. Proc. Natl. Acad. Sci. USA 89:5547-5551; 1992.
18. Wyllie, F. S.; Haughton, M. F.; Bond, J. A.; Rowson, J. M.; Jones, C. J.; Wynford-Thomas, D. S shape cell-cycle arrest following DNA damage is independent of the p53/p21 (WAF1) signalling pathway. Oncogene 12:1077-1082; 1996.
19. Zaffaroni, N.; Silvestrini, R.; Orlandi, L.; Bearzatto, A.; Gornati, D.; Villa, R. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-regulated proteins in cisplatin-sensitive and resistant human ovarian cells. Br. J. Cancer 77:1378-1385; 1998.
20. Roth, W.; Wagenknecht, B.; Grimmel, C.; Dichgans, J. Weller, M. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: Association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br. J. Cancer 77:40-4-411; 1998.
21. Iwadate, Y.; Tagawa, M.; Fujimoto, S.; Hirose, M.; Namba, H.; Sueyoshi, K.,; Sakiyama, S.; Yamaura, A. Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anticancer agents. Br. J. Cancer 77:547-551; 1998.
22. Verma, R.; Mayor, S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394:798-801; 1998.
23. Friedrichson, T.; Kurzchalia, T. V. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394:802-805; 1998.